We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Review · June 30, 2022

Drug Development for Hereditary Cancer Syndromes in the Light of Genomic Defects

American Society of Clinical Oncology educational book / ASCO

 

Additional Info

American Society of Clinical Oncology educational book / ASCO
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects
Am Soc Clin Oncol Educ Book 2022 Apr 01;42(2022)1-17, E Hasanov, I Pimentel, M Cruellas, MA Lewis, E Jonasch, J Balmaña

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading